NEW YORK (GenomeWeb) – OncoDNA announced today that it will help perform patient stratification in a Phase II precision medicine study in head and neck cancer being run by the European Organization for Research and Treatment of Cancer.
NEW YORK (GenomeWeb) – OncoDNA announced today that it will help perform patient stratification in a Phase II precision medicine study in head and neck cancer being run by the European Organization for Research and Treatment of Cancer.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.
Privacy Policy. Terms & Conditions. . Copyright © 2021 GenomeWeb, a business unit of Crain Communications. All Rights Reserved.